Expanding ERG in Diabetic Eye Care
November 28, 2025
-
6 min
3 Key Takeaways
-
1
- Diabetic retinopathy affected
-
2
6 million in the US in 202
-
3
- Nearly 2 million are in vision-threatening stages. - Handheld ERG devices are efficient and non-invasive. - ERG detects functional changes before structural ones. - RETeval DR Score predicts progression to complications. - ERG is included in AAO guidelines for diabetic retinopathy. - Early intervention can preserve vision outcomes.
Diabetic retinopathy is increasingly prevalent, affecting an estimated 9.6 million individuals in the US, with nearly 2 million at the vision-threatening stage. As the need for effective risk management rises, electroretinography (ERG) emerges as a valuable tool to identify functional retinal changes before structural alterations. Current handheld ERG devices facilitate efficient, non-invasive testing. Recent studies highlight ERG's predictive capabilities, prompting a shift in diabetic eye care towards proactive intervention strategies focused on preserving vision.
Listen Tab content
